Application of microfluidic technology in antibody screening.

Area of Science:

• Biomedical Science
• Biotechnology
• Analytical Chemistry

Background:

• Specific antibodies are crucial in biomedical research and diagnostics.
• Current antibody screening methods (hybridoma, antibody engineering) face challenges like inefficiency, high cost, and automation limitations.
• These limitations hinder the rapid discovery and development of specific antibodies.

Purpose of the Study:

• To review recent advancements in microfluidic applications for specific antibody screening.
• To highlight how microfluidics overcomes bottlenecks in traditional antibody screening.
• To discuss microfluidic integration with various antibody engineering techniques.

Main Methods:

• Review of microfluidic platforms applied to antibody screening.
• Integration of microfluidics with hybridoma technology.
• Application of microfluidics in antibody engineering techniques: phage display, single B cell screening, antibody expression, and cell-free protein synthesis.

Main Results:

• Microfluidics enables high-throughput and high-purity screening of specific antibodies.
• Demonstrated successful integration of microfluidics with established antibody discovery platforms.
• Identified microfluidics as a key enabling technology for overcoming current screening limitations.

Conclusions:

• Microfluidics presents a significant advancement for efficient and precise antibody screening.
• The technology holds great potential for accelerating antibody discovery and development.
• Future research should focus on further optimizing microfluidic systems and exploring new applications.